Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 6, 1997, Pages 534-539

  Joschko, Marion A ^a   Webster, Lorraine K ^a   Bishop, James F ^a   Groves, Janice ^a   Yuen, Kally ^a   Olver, Ian N ^b   Narayan, Kailash N ^a   Ball, David L ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Cisplatin; Radiation enhancement; Squamous carcinoma; Tumour growth delay; Xenograft

Indexed keywords

CISPLATIN; PLATINUM;

ANIMAL MODEL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; RADIOTHERAPY; TUMOR; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; TUMOR CELLS, CULTURED;

EID: 0030810497     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050699     Document Type: Article

References (20)

1. Begg AC, Deurloo MJM, Kop W, Bartelink H (1994) Improvement of combined modality therapy with cisplatin and radiation using intratumoral drug administration in murine tumors. Radiother Oncol 31: 129-137
2. De Andres L, Brunei J, Lopez-Pousa A, Burgues J, Vega M, Tabernero JM, Mesia R, Lopez JJ (1995) Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and flourouracil in patients with stage IV-M0 head and neck cancer. J Clin Oncol 13: 1493-1500
3. Douple EB, Richmond RC, O'Hara JA, Coughlin CT (1985) Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 12: 111-124
4. Fu KK, Lam KN, Rayner PA (1985) The influence of time sequence of cisplatin administration and continuous low dose rate irradiation on their combined effects on a murine squamous cell carcinoma. Int J Radiat Oncol Biol Phys 11: 2119-2124
5. Glicksman AS, Slotman G, Doolittle C, Clark J, Koness J, Coachman N, Posner M, DeRosa E, Wanebo H (1994) Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 30: 1043-1050
6. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598
7. Joschko MA, Webster LK, Groves J, Yuen K, Bishop JF, Millward MJ, Ball DL (1997) Schedule-dependent radiation enhancement by paclitaxel with accelerated fractionated radiation in a human squamous carcinoma xenograft. Radiat Oncol Invest 4: 268-274
8. Kallman RF, Rapacchietta D, Zaghloul M (1991) Schedule dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems. Int J Radiat Oncol Biol Phys 20: 227-232
9. Kubota T, Inoue S, Furukawa T, Ishibiki K, Kitajiina M, Kawamura E, Huffman RM (1993) Similarity of serum-tumor pharmacokinetics of antitumor agents in man and nude mice. Anticancer Res 13: 1481-1484
10. Kyriazis AP, Kyriazis AA, Yagoda A (1986) Time dependence of the radiation-modifying effect of cis-diamminedichloroplat inum II on human urothelial cancer grown in nude mice. Cancer Invest 4: 217-222
11. Milas L, Hunter NR, Mason KA, Kurdoglu B, Peters LJ (1994) Enhancement of tumor radioresponsive of a murine mammary carcinoma by paclitaxel. Cancer Res 54: 3506-3510
12. Non-Small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311: 899-909
13. Schaake-Koning C, Bogaert W van den, Dalesio O, Festen J, Hoogenhout J, Houtte P van, Kirkpatrick A, Koolen M, Maat G, Nijs A, Renaud A, Rodrigus P, Sehuster-Uitterhoeve L, Sculier J, Zandwijk N van, Bartelink H (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524-530
14. Schwachhofer JHM, Hoogenhout J, Kal HB, Koedam J, Wezel HPN van (1990) Radiosensitivity of different human tumor lines grown as xenografts determined from growth delay and survival data. In Vivo 4: 253-257
15. Steel GG, Courtenay VD, Peckham MJ (1983) The response to chemotherapy of a variety of human tumor xenoerafts. Br J Cancer 47: 1-13
16. Sun J, Brown JM (1993) Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Radiat Res 133: 252-256
17. Tavlor SG, Murthy AK, Vannetzel J-M, Colin P, Dray M, Calderelli S, Shott E, Yokes E, Showel JL, Hutchinson JC, Witt TR, Griem WE, Hartsell MS, Kies B, Mittal JL, Rebischung DJ, Coupez JL, Desphieux S, Bobin S, LePajolec C (1994) Randomised comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12: 385-395
18. Twentyman PR, Kallman RF, Brown JM (1979) The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. III. cis-Diamminedichloroplatinum. Int J Radiat Oncol Biol Phys 5: 1365-1367
19. Wheeler JA, Stephens LC, Milas L, Hunter NR, Willingham VI, Meyn RE (1996) Cisplatin-induced enhancement of radio-response in a murine mammary carcinoma: test of a role for apoptosis. Radiat Oncol Invest 3: 225-231
20. Withers HR (1985) Biological basis for altered fractionation schemes. Cancer 55: 2086